DCLK1 and familial pancreatic carcinoma: To further evaluate DCLK1 protein expression in PDAC tumors, we performed immunohistochemistry using anti-DCLK1 antibody on a commercially available tissue microarray with tumor and normal adjacent tissues (NAT) from stages I/II pancreatic cancer patients.